Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000762676 | SCV000893011 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | IDS: BS2 |
Labcorp Genetics |
RCV001083047 | SCV001091905 | benign | Mucopolysaccharidosis, MPS-II | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000762676 | SCV001819949 | likely benign | not provided | 2018-06-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002332544 | SCV002638839 | likely benign | Inborn genetic diseases | 2016-10-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001825511 | SCV002084491 | likely benign | Mucopolysaccharidosis, MPS-III-A | 2019-10-28 | no assertion criteria provided | clinical testing |